{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,22]],"date-time":"2025-11-22T16:05:51Z","timestamp":1763827551236,"version":"3.45.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T00:00:00Z","timestamp":1761264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T00:00:00Z","timestamp":1761264000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Center for international Scientific studies & Collaborations (CISSC), Ministry of science Research and Technology of Iran","award":["4020467"],"award-info":[{"award-number":["4020467"]}]},{"name":"National Institute of Genetic Engineering and Biotechnology of Iran","award":["912"],"award-info":[{"award-number":["912"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"DOI":"10.1007\/s12032-025-03085-6","type":"journal-article","created":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T02:34:45Z","timestamp":1761273285000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Silencing SOX2OT reduces viability and migration in lung cancer cells via lncRNA and protein regulation"],"prefix":"10.1007","volume":"42","author":[{"given":"Mohadeseh","family":"Zarei","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Dinari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Babak","family":"Jahangiri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elahe","family":"Asadollahi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jamshid","family":"Raheb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,24]]},"reference":[{"key":"3085_CR1","doi-asserted-by":"publisher","first-page":"102693","DOI":"10.1016\/j.canep.2024.102693","volume":"93","author":"J Zhou","year":"2024","unstructured":"Zhou J, Xu Y, Liu J, Feng L, Yu J, Chen D. Global burden of lung cancer in 2022 and projections to 2050: incidence and mortality estimates from GLOBOCAN. Cancer Epidemiol. 2024;93:102693.","journal-title":"Cancer Epidemiol"},{"issue":"1","key":"3085_CR2","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1186\/s12889-025-22450-8","volume":"25","author":"Y Zhang","year":"2025","unstructured":"Zhang Y, Wang W, Dai K, Huang Y, Wang R, He D, et al. Global lung cancer burden attributable to air fine particulate matter and tobacco smoke exposure: spatiotemporal patterns, sociodemographic characteristics, and transnational inequalities from 1990 to 2021. BMC Public Health. 2025;25(1):1260.","journal-title":"BMC Public Health"},{"issue":"3","key":"3085_CR3","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer J Clin. 2024;74(3):229\u201363.","journal-title":"CA: A Cancer J Clin."},{"key":"3085_CR4","doi-asserted-by":"publisher","first-page":"1521700","DOI":"10.3389\/fimmu.2025.1521700","volume":"16","author":"E Asadollahi","year":"2025","unstructured":"Asadollahi E, Zomorodipour A, Soheili Z-S, Jahangiri B, Sadeghizadeh M. Development of a multi-neoepitope vaccine targeting non-small cell lung cancer through reverse vaccinology and bioinformatics approaches. Front Immunol. 2025;16:1521700.","journal-title":"Front Immunol"},{"issue":"3","key":"3085_CR5","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/s41576-023-00662-1","volume":"25","author":"K Nemeth","year":"2024","unstructured":"Nemeth K, Bayraktar R, Ferracin M, Calin GA. Non-coding RNAs in disease: from mechanisms to therapeutics. Nat Rev Genet. 2024;25(3):211\u201332.","journal-title":"Nat Rev Genet"},{"issue":"5830","key":"3085_CR6","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1126\/science.1138341","volume":"316","author":"P Kapranov","year":"2007","unstructured":"Kapranov P, Cheng J, Dike S, Nix DA, Duttagupta R, Willingham AT, et al. RNA maps reveal new RNA classes and a possible function for pervasive transcription. Science. 2007;316(5830):1484\u20138.","journal-title":"Science"},{"key":"3085_CR7","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s12079-018-0471-5","volume":"13","author":"B Jahangiri","year":"2019","unstructured":"Jahangiri B, Khalaj-Kondori M, Asadollahi E, Sadeghizadeh M. Cancer-associated fibroblasts enhance cell proliferation and metastasis of colorectal cancer SW480 cells by provoking long noncoding RNA UCA1. J Cell Commun Signal. 2019;13:53\u201364.","journal-title":"J Cell Commun Signal"},{"issue":"5","key":"3085_CR8","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.tig.2015.03.007","volume":"31","author":"GS Laurent","year":"2015","unstructured":"Laurent GS, Wahlestedt C, Kapranov P. The landscape of long noncoding RNA classification. Trends Genet. 2015;31(5):239\u201351.","journal-title":"Trends Genet"},{"issue":"7364","key":"3085_CR9","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/nature10398","volume":"477","author":"M Guttman","year":"2011","unstructured":"Guttman M, Donaghey J, Carey BW, Garber M, Grenier JK, Munson G, et al. LincRNAs act in the circuitry controlling pluripotency and differentiation. Nature. 2011;477(7364):295\u2013300.","journal-title":"Nature"},{"key":"3085_CR10","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1007\/s10620-020-06200-x","volume":"66","author":"M Khajehdehi","year":"2021","unstructured":"Khajehdehi M, Khalaj-Kondori M, Ghasemi T, Jahanghiri B, Damaghi M. Long noncoding RNAs in gastrointestinal cancer: tumor suppression versus tumor promotion. Dig Dis Sci. 2021;66:381\u201397.","journal-title":"Dig Dis Sci"},{"issue":"6","key":"3085_CR11","doi-asserted-by":"publisher","first-page":"703","DOI":"10.4161\/rna.20481","volume":"9","author":"T Gutschner","year":"2012","unstructured":"Gutschner T, Diederichs S. The hallmarks of cancer: a long non-coding RNA point of view. RNA Biol. 2012;9(6):703\u201319.","journal-title":"RNA Biol"},{"issue":"5","key":"3085_CR12","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1158\/2159-8290.CD-11-0209","volume":"1","author":"JR Prensner","year":"2011","unstructured":"Prensner JR, Chinnaiyan AM. The emergence of lncRNAs in cancer biology. Cancer Discov. 2011;1(5):391\u2013407.","journal-title":"Cancer Discov"},{"issue":"2","key":"3085_CR13","doi-asserted-by":"publisher","first-page":"200785","DOI":"10.1016\/j.omton.2024.200785","volume":"32","author":"AS Pathania","year":"2024","unstructured":"Pathania AS, Chava H, Balusu R, Pasupulati AK, Coulter DW, Challagundla KB. The crosstalk between non-coding RNAs and cell-cycle events: A new frontier in cancer therapy. Mol Ther Oncol. 2024;32(2):200785.","journal-title":"Mol Ther Oncol"},{"key":"3085_CR14","doi-asserted-by":"publisher","first-page":"23","DOI":"10.3389\/fmed.2015.00023","volume":"2","author":"M Morlando","year":"2015","unstructured":"Morlando M, Ballarino M, Fatica AJ. Long non-coding RNAs: new players in hematopoiesis and leukemia. Front Med. 2015;2:23.","journal-title":"Front Med"},{"issue":"1","key":"3085_CR15","first-page":"5365209","volume":"2016","author":"M Losko","year":"2016","unstructured":"Losko M, Kotlinowski J, Jura J. Long noncoding RNAs in metabolic syndrome related disorders. Mediators Inflamm. 2016;2016(1):5365209.","journal-title":"Mediators Inflamm"},{"key":"3085_CR16","doi-asserted-by":"publisher","first-page":"111919","DOI":"10.1016\/j.cellsig.2025.111919","volume":"134","author":"H Zhang","year":"2025","unstructured":"Zhang H, He X, Yang L, Yang F, Chen R, Wen Z, et al. Trim45: an emerging E3 ubiquitin ligases in cancer. Cell Signal. 2025;134:111919.","journal-title":"Cell Signal"},{"key":"3085_CR17","doi-asserted-by":"publisher","first-page":"111977","DOI":"10.1016\/j.cellsig.2025.111977","volume":"135","author":"R Fu","year":"2025","unstructured":"Fu R, Sun F, Wang W, Wang R, Zhang H, He X, et al. SHMT proteins: An emerging set of serine hydroxymethyltransferase in cancer. Cell Signal. 2025;135:111977.","journal-title":"Cell Signal"},{"issue":"1","key":"3085_CR18","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s13105-024-01059-2","volume":"81","author":"J Yang","year":"2025","unstructured":"Yang J, Tan F, Chen Y, Li X, Yuan C. The emerging role of long non-coding RNA SOX2-OT in cancers and non-malignant diseases. J Physiol Biochem. 2025;81(1):57\u201383.","journal-title":"J Physiol Biochem"},{"issue":"1","key":"3085_CR19","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1186\/s43042-025-00748-x","volume":"26","author":"M Yousefi","year":"2025","unstructured":"Yousefi M, Karimi M, Rezaei A, Mortezazadeh M, Akhshabi S, Yousefi Ladmakhi A, et al. Evaluation of lncRNA SOX2OT gene expression in breast cancer patients and its association with prognosis of disease: a paired sample study. Egypt J Med Human Genetics. 2025;26(1):123.","journal-title":"Egypt J Med Human Genetics"},{"issue":"1","key":"3085_CR20","doi-asserted-by":"publisher","first-page":"12371","DOI":"10.1038\/s41598-023-39000-0","volume":"13","author":"F Dodangeh","year":"2023","unstructured":"Dodangeh F, Sadeghi Z, Maleki P, Raheb J. Long non-coding RNA SOX2-OT enhances cancer biological traits via sponging to tumor suppressor miR-122-3p and miR-194-5p in non-small cell lung carcinoma. Sci Rep. 2023;13(1):12371.","journal-title":"Sci Rep"},{"key":"3085_CR21","doi-asserted-by":"publisher","first-page":"109921","DOI":"10.1016\/j.biopha.2020.109921","volume":"124","author":"Y Zhou","year":"2020","unstructured":"Zhou Y, Tian B, Tang J, Wu J, Wang H, Wu Z, et al. SNHG7: a novel vital oncogenic lncRNA in human cancers. Biomed Pharmacother. 2020;124:109921.","journal-title":"Biomed Pharmacother"},{"key":"3085_CR22","doi-asserted-by":"publisher","first-page":"809345","DOI":"10.3389\/fcell.2021.809345","volume":"9","author":"S Najafi","year":"2022","unstructured":"Najafi S, Ghafouri-Fard S, Hussen BM, Jamal HH, Taheri M, Hallajnejad M. Oncogenic roles of small nucleolar RNA host gene 7 (SNHG7) long noncoding RNA in human cancers and potentials. Front Cell Dev Biol. 2022;9:809345.","journal-title":"Front Cell Dev Biol"},{"issue":"17","key":"3085_CR23","doi-asserted-by":"publisher","first-page":"23212","DOI":"10.18632\/oncotarget.6745","volume":"7","author":"E Zhang","year":"2015","unstructured":"Zhang E, Yin D, Han L, He X, Si X, Chen W, et al. E2F1-induced upregulation of long noncoding RNA LINC00668 predicts a poor prognosis of gastric cancer and promotes cell proliferation through epigenetically silencing of CKIs. Oncotarget. 2015;7(17):23212.","journal-title":"Oncotarget"},{"issue":"27","key":"3085_CR24","doi-asserted-by":"publisher","first-page":"19443","DOI":"10.18632\/oncotarget.23821","volume":"9","author":"Z Zhou","year":"2017","unstructured":"Zhou Z, Lin Z, Pang X, Tariq MA, Ao X, Li P, et al. Epigenetic regulation of long non-coding RNAs in gastric cancer. Oncotarget. 2017;9(27):19443.","journal-title":"Oncotarget"},{"issue":"3","key":"3085_CR25","doi-asserted-by":"publisher","first-page":"544","DOI":"10.3390\/biomedicines12030544","volume":"12","author":"PV Ershov","year":"2024","unstructured":"Ershov PV, Yablokov EO, Mezentsev YV, Ivanov AS. Long intergenic non-coding RNAs of human chromosome 18: focus on cancers. Biomedicines. 2024;12(3):544.","journal-title":"Biomedicines"},{"issue":"7","key":"3085_CR26","doi-asserted-by":"publisher","first-page":"BSR20191210","DOI":"10.1042\/BSR20191210","volume":"39","author":"D Xu","year":"2019","unstructured":"Xu D, Yu J, Zhuang S, Zhang S, Hong Z, Yuan C. Overexpression of long non-coding RNA LINC00982 suppresses cell proliferation and tumor growth of papillary thyroid carcinoma through PI3K-ATK signaling pathway. Biosci Rep. 2019;39(7):BSR20191210.","journal-title":"Biosci Rep"},{"issue":"5","key":"3085_CR27","first-page":"2698","volume":"40","author":"W Lv","year":"2018","unstructured":"Lv W, Yu X, Li W, Feng N, Feng T, Wang Y, et al. Low expression of LINC00982 and PRDM16 is associated with altered gene expression, damaged pathways and poor survival in lung adenocarcinoma. Oncol Rep. 2018;40(5):2698\u2013709.","journal-title":"Oncol Rep"},{"issue":"4","key":"3085_CR28","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1089\/dna.2021.0866","volume":"41","author":"F Chi","year":"2022","unstructured":"Chi F, Qiu F, Jin X, Chen L, He G, Han S. LINC00982 inhibits the proliferation, migration, and invasion of breast cancer cells through the miR-765\/DPF3 axis. DNA Cell Biol. 2022;41(4):424\u201336.","journal-title":"DNA Cell Biol"},{"issue":"5","key":"3085_CR29","doi-asserted-by":"publisher","first-page":"2580","DOI":"10.21037\/tcr-24-2155","volume":"14","author":"S Xiang","year":"2025","unstructured":"Xiang S, Zhang W, Wang Z, Chen H, Yang C. Evaluating HSP90AA1 as a predictive biomarker for prognosis in lung adenocarcinoma. Transl Cancer Res. 2025;14(5):2580.","journal-title":"Transl Cancer Res"},{"key":"3085_CR30","doi-asserted-by":"publisher","first-page":"149330","DOI":"10.1016\/j.bbrc.2023.149330","volume":"692","author":"S Li","year":"2024","unstructured":"Li S, Shi J, Wang L, Zhang D, Zhang H. EP300 promotes lung cancer cell proliferation by regulating the oncogenic transcription of Hippo-YAP signaling pathway. Biochem Biophys Res Commun. 2024;692:149330.","journal-title":"Biochem Biophys Res Commun"},{"issue":"5","key":"3085_CR31","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1007\/s00204-024-03693-7","volume":"98","author":"E Kook","year":"2024","unstructured":"Kook E, Lee J, Kim D-H. YES1 as a potential target to overcome drug resistance in EGFR-deregulated non-small cell lung cancer. Arch Toxicol. 2024;98(5):1437\u201355.","journal-title":"Arch Toxicol"},{"issue":"11","key":"3085_CR32","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1097\/JTO.0b013e3182a46c0c","volume":"8","author":"KW Tam","year":"2013","unstructured":"Tam KW, Zhang W, Soh J, Stastny V, Chen M, Sun H, et al. CDKN2A\/p16 inactivation mechanisms and their relationship to smoke exposure and molecular features in non\u2013small-cell lung cancer. J Thorac Oncol. 2013;8(11):1378\u201388.","journal-title":"J Thorac Oncol"},{"issue":"22","key":"3085_CR33","doi-asserted-by":"publisher","first-page":"e2416723122","DOI":"10.1073\/pnas.2416723122","volume":"122","author":"SR Cook","year":"2025","unstructured":"Cook SR, Hugen S, Hayward JJ, Famula TR, Belanger JM, McNiel E, et al. Genomic analyses identify 15 risk loci and reveal HDAC2, SOX2-OT, and IGF2BP2 in a naturally occurring canine model of gastric cancer. Proc Natl Acad Sci. 2025;122(22):e2416723122.","journal-title":"Proc Natl Acad Sci"},{"key":"3085_CR34","doi-asserted-by":"publisher","first-page":"109725","DOI":"10.1016\/j.biopha.2019.109725","volume":"123","author":"Y Wang","year":"2020","unstructured":"Wang Y, Wu N, Luo X, Zhang X, Liao Q, Wang J. SOX2OT, a novel tumor-related long non-coding RNA. Biomed Pharmacother. 2020;123:109725.","journal-title":"Biomed Pharmacother"},{"issue":"10","key":"3085_CR35","first-page":"1431","volume":"42","author":"D Hongliang","year":"2022","unstructured":"Hongliang D, Lili Z, Yan W, Shuang M, Na N, Naiguo L, et al. SOX2-OT\/SOX2 axis regulates lung cancer H520 cell migration via Gli1-mediated epithelial-mesenchymal transition. J South Med Univ. 2022;42(10):1431.","journal-title":"J South Med Univ"},{"issue":"3","key":"3085_CR36","first-page":"e3530","volume":"21","author":"Z Sadeghi","year":"2023","unstructured":"Sadeghi Z, Raheb J. SOX2 overlapping transcript (SOX2-OT) enhances the lung cancer malignancy through interaction with miR-194-5p\/SOX5 axis. Iran J Biotechnol. 2023;21(3):e3530.","journal-title":"Iran J Biotechnol"},{"key":"3085_CR37","doi-asserted-by":"publisher","first-page":"674856","DOI":"10.3389\/fgene.2021.674856","volume":"12","author":"Z Chen","year":"2021","unstructured":"Chen Z, Chen Z, Xu S, Zhang Q. LncRNA SOX2-OT\/miR-30d-5p\/PDK1 regulates PD-L1 checkpoint through the mTOR signaling pathway to promote non-small cell lung cancer progression and immune escape. Front Genet. 2021;12:674856.","journal-title":"Front Genet"},{"issue":"5","key":"3085_CR38","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1038\/s41389-020-0242-z","volume":"9","author":"Y Liang","year":"2020","unstructured":"Liang Y, Zhang D, Zheng T, Yang G, Wang J, Meng F, et al. lncRNA-SOX2OT promotes hepatocellular carcinoma invasion and metastasis through miR-122-5p-mediated activation of PKM2. Oncogenesis. 2020;9(5):54.","journal-title":"Oncogenesis"},{"issue":"5","key":"3085_CR39","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1038\/s41419-021-03756-y","volume":"12","author":"Y Feng","year":"2021","unstructured":"Feng Y, Xu Y, Gao Y, Chen Y, Wang X, Chen Z. A novel lncRNA SOX2OT promotes the malignancy of human colorectal cancer by interacting with miR-194-5p\/SOX5 axis. Cell Death Dis. 2021;12(5):499.","journal-title":"Cell Death Dis"},{"issue":"11","key":"3085_CR40","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1080\/15384101.2020.1750812","volume":"19","author":"X Chang","year":"2020","unstructured":"Chang X, Zhang H, Yang Q, Pang L. LncRNA SOX2OT affects cervical cancer cell growth, migration and invasion by regulating SOX2. Cell Cycle. 2020;19(11):1391\u2013403.","journal-title":"Cell Cycle"},{"key":"3085_CR41","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.cca.2018.05.038","volume":"484","author":"X Song","year":"2018","unstructured":"Song X, Yao H, Liu J, Wang Q. The prognostic value of long noncoding RNA SOX2OT expression in various cancers: a systematic review and meta-analysis. Clin Chim Acta. 2018;484:52\u20139.","journal-title":"Clin Chim Acta"},{"key":"3085_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/14796694.2025.2542051","volume":"21","author":"TD Bazan Russo","year":"2025","unstructured":"Bazan Russo TD, Pepe F, Gristina V, Gottardo A, Russo G, Scimone C, et al. Recent advances in liquid biopsy for precision oncology: emerging biomarkers and clinical applications in lung cancer. Future Oncol. 2025;21:1\u201319.","journal-title":"Future Oncol"},{"issue":"5","key":"3085_CR43","doi-asserted-by":"publisher","first-page":"e0176889","DOI":"10.1371\/journal.pone.0176889","volume":"12","author":"X Jing","year":"2017","unstructured":"Jing X, Lin J, Wang H, Tian L, Tian R, Zhang Y, et al. Prognostic value of lncRNA SOX2OT for Chinese cancer patients: a meta-analysis. PLoS ONE. 2017;12(5):e0176889.","journal-title":"PLoS ONE"},{"key":"3085_CR44","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.3389\/fgene.2019.01375","volume":"10","author":"Y Li","year":"2020","unstructured":"Li Y, Du M, Wang S, Zha J, Lei P, Wang X, et al. Clinicopathological implication of long non-coding RNAs SOX2 overlapping transcript and its potential target gene network in various cancers. Front Genet. 2020;10:1375.","journal-title":"Front Genet"},{"issue":"4","key":"3085_CR45","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1002\/1878-0261.12875","volume":"15","author":"AM Herrera-Solorio","year":"2021","unstructured":"Herrera-Solorio AM, Peralta-Arrieta I, Armas Lopez L, Hern\u00e1ndez-Cigala N, Mendoza Milla C, Ortiz Quintero B, et al. LncRNA SOX2-OT regulates AKT\/ERK and SOX2\/GLI-1 expression, hinders therapy, and worsens clinical prognosis in malignant lung diseases. Mol Oncol. 2021;15(4):1110\u201329.","journal-title":"Mol Oncol"},{"issue":"1","key":"3085_CR46","doi-asserted-by":"publisher","first-page":"2901589","DOI":"10.1155\/2020\/2901589","volume":"2020","author":"P-Y Li","year":"2020","unstructured":"Li P-Y, Wang P, Gao S-G, Dong D-Y. Long noncoding RNA SOX2-OT: regulations, functions, and roles on mental illnesses, cancers, and diabetic complications. Biomed Res Int. 2020;2020(1):2901589.","journal-title":"Biomed Res Int"},{"issue":"8","key":"3085_CR47","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1002\/ijc.27316","volume":"130","author":"H Rayess","year":"2012","unstructured":"Rayess H, Wang MB, Srivatsan ES. Cellular senescence and tumor suppressor gene p16. Int J Cancer. 2012;130(8):1715\u201325.","journal-title":"Int J Cancer"},{"issue":"12","key":"3085_CR48","doi-asserted-by":"publisher","first-page":"jcs261028","DOI":"10.1242\/jcs.261028","volume":"136","author":"Y Xu","year":"2023","unstructured":"Xu Y, Wan W. Emerging roles of p300\/CBP in autophagy and autophagy-related human disorders. J Cell Sci. 2023;136(12):jcs261028.","journal-title":"J Cell Sci"},{"issue":"3","key":"3085_CR49","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.3390\/ijms25031450","volume":"25","author":"E Kook","year":"2024","unstructured":"Kook E, Chun K-S, Kim D-H. Emerging roles of YES1 in cancer: the putative target in drug resistance. Int J Mol Sci. 2024;25(3):1450.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"3085_CR50","doi-asserted-by":"publisher","first-page":"e320","DOI":"10.1038\/oncsis.2017.5","volume":"6","author":"M Sen","year":"2017","unstructured":"Sen M, Akeno N, Reece A, Miller A, Simpson D, Wikenheiser-Brokamp K. p16 controls epithelial cell growth and suppresses carcinogenesis through mechanisms that do not require RB1 function. Oncogenesis. 2017;6(4):e320.","journal-title":"Oncogenesis"},{"issue":"5","key":"3085_CR51","doi-asserted-by":"publisher","first-page":"45","DOI":"10.3892\/mco.2020.2115","volume":"13","author":"Z Bian","year":"2020","unstructured":"Bian Z, Ji W, Xu B, Huang W, Jiao J, Shao J, et al. The role of long noncoding RNA SNHG7 in human cancers. Mol Clin Oncol. 2020;13(5):45.","journal-title":"Mol Clin Oncol"},{"issue":"2","key":"3085_CR52","first-page":"2182","volume":"15","author":"L Han","year":"2018","unstructured":"Han L, Zhang W, Zhang B, Zhan L. Long non-coding RNA SOX2OT promotes cell proliferation and motility in human ovarian cancer. Exp Ther Med. 2018;15(2):2182\u20138.","journal-title":"Exp Ther Med"},{"issue":"9","key":"3085_CR53","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1007\/s12032-025-02969-x","volume":"42","author":"D Yu","year":"2025","unstructured":"Yu D, Zhang H, Ding X, Guo J, Yang L. VAMP proteins: molecular architects in disease pathogenesis and therapeutic innovation. Med Oncol. 2025;42(9):411.","journal-title":"Med Oncol"},{"issue":"2","key":"3085_CR54","doi-asserted-by":"publisher","first-page":"199","DOI":"10.3724\/abbs.2024014","volume":"56","author":"H Zhang","year":"2024","unstructured":"Zhang H, Yang J, Song Q, Ding X, Sun F, Yang L. UBA3 promotes the occurrence and metastasis of intrahepatic cholangiocarcinoma through MAPK signaling pathway: UBA3 promotes the occurrence and metastasis of ICC. Acta Biochim Biophys Sin. 2024;56(2):199.","journal-title":"Acta Biochim Biophys Sin"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-025-03085-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12032-025-03085-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-025-03085-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,22]],"date-time":"2025-11-22T16:02:16Z","timestamp":1763827336000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12032-025-03085-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,24]]},"references-count":54,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3085"],"URL":"https:\/\/doi.org\/10.1007\/s12032-025-03085-6","relation":{},"ISSN":["1559-131X"],"issn-type":[{"type":"electronic","value":"1559-131X"}],"subject":[],"published":{"date-parts":[[2025,10,24]]},"assertion":[{"value":"20 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}},{"value":"Ethics approval was not applicable, as this study did not involve human participants or animal models. All cell lines (A549 and Calu-3) were obtained from Pasteur Institute of Iran and were authenticated by short tandem repeat (STR) profiling. Cells were routinely tested and confirmed to be free of mycoplasma contamination.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"528"}}